The VHR Dual-Specificity Protein Tyrosine Phosphatase (DS-PTPase) Inhibitor Isolated from Gastrodia elata

천마(Gastrodia elata)로부터 분리한 VHR DS-PTPase 저해 물질

  • Lee, Myung-Sun (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Oh, Won-Keun (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Bae, Eun-Young (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Ahn, Soon-Cheol (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Sohn, Cheon-Bae (Department of Food and Nutrition, Chungnam National University) ;
  • Osada, Hiroyuki (The Institute of Physical and Chemical Research (RIKEN)) ;
  • Ahn, Jong-Seog (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
  • Published : 2002.06.01

Abstract

In the course of screening program for VHR DS-PTPase (dual-specificity protein tyrosine phosphatase) from natural sources, Gastrodia elata was selected. One compound showing potent inhibitory activity was isolated by the solvent extraction and column chromatography including silica gel, ODS RP-18, Sephades LH-20, and HPLC. This compound was identified as baicalein by several NMR techniques such as $^1H-NMR$, $^{13}C-NMR$, and DEPT. Baicalein showed selective inhibitory activity against VHR DS-PTPase with $IC_{50}=2.4\;{\mu}M$, and showed cytotoxicity against several human cancer cell lines with an $GI_{50}$ of $5.26{\sim}12.93\;{\mu}g/mL$ range, including, melanoma (LOX-IMVI), lung cancer (NCI H23 and A549), colon cancer (HCT 116 and SW 620), prostate cancer (PC-3), and leukemia (MOLT 4F).

천마의 methanol 추출물로부터 VHR DS-PTPase 저해 물질을 분리하여 이를 HREI-MS와 $^1H-NMR$, $^{13}C-NMR$, DEPT 등의 기기 분석 자료에 의하여 baicalein으로 구조를 동정 하였다. 이 물질은 VHR에 대하여 $2.4{\mu}M$$IC_{50}$값을 나타내었고 T-cell PTPase나 PPase 1과 같은 다른 단백질 탈인산화 효소에 대하여는 저해 활성을 나타내지 않았다. 또한 7종류의 인간 암세포주(흑색종 세포주인 LOX-IMVI, 폐암 세포주인 NCI H23과 A549, 대장암 세포주인 HCT 116와 SW 620, 전립선암 세포주인 PC-3와 백혈병 세포주인 MOLT 4F)에 대한 세포독성을 조사하여 본 결과 $5.26{\sim}12.93\;{\mu}g/mL$에서 $GI_{50}$값을 나타내었다.

Keywords

References

  1. Camps, M., Nichols, A. and Arkinstall, S. Dual specificity phos phatases: a gene family for control of MAP kinase function. FASEB J. 14: 6-16 (2000) https://doi.org/10.1096/fasebj.14.1.6
  2. Guan, K., Broyles, S.S. and Dixon, J.E. A Thr/Ser protein phosphatase encoded by vaccinia virus. Nature 350: 359-362 (1991) https://doi.org/10.1038/350359a0
  3. Martell, K.J., Angelotti, T, Ullrich, A. The 'VHl-like' dual-specifcity protein tyrosine phosphatases. Mol. Cells 8: 2-11 (1998)
  4. Sodeoka, M., Sampe, R., Kojima, S., Baba, Y., Usui, T, Ueda, K. and Osada, H. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. J. Med. Chem. 44: 3216-3222 (2001) https://doi.org/10.1021/jm0100741
  5. Usui, T., Kojima, S., Kidokoro, S., Ueda, K., Osada, H. and Sodeoka, M. Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory acdvity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition. Chem. Biol. 8: 1209-1220 (2001) https://doi.org/10.1016/S1074-5521(01)00089-8
  6. Galaktionov, K. and Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotis cyclins. Cell 67: 1181-1194 (1991) https://doi.org/10.1016/0092-8674(91)90294-9
  7. Hannon, G.J., Casso, D. and Beach, D. KAP: A dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc. Natl, Acad. Sci. USA 91: 1731-1735 (1994)
  8. Gyuris, J., Golemis, E., Chertkov, H. and Brent, R. Cdil, a human Gl and S phase protein phosphatase that associates with Cdk2. Cell 75: 791-803 (1993) https://doi.org/10.1016/0092-8674(93)90498-F
  9. Sun, H., Charles, C.H., Lau, L.F. and Tonks, N.K. MKP-l (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP Kinase in vivo. Cell 75: 487-493 (1993) https://doi.org/10.1016/0092-8674(93)90383-2
  10. Alonso, A., Merlo, J.J., Na, S., Kholod, N., Jaroszewski, L., Khantonenkov, A., Williams, S., Godzik, A., Posada, J.D. and Mustelin, T. Inhibition of T cell antigen receptor signaling by VHX, a new dual-specificity phosphatase related to VHR. J. Biol. Chem. 277: 5524-5528 (2001) https://doi.org/10.1074/jbc.M107653200
  11. Najarro, P., Traktman, P. and Lewis, J.A. Vaccinia virus blocks gamma interferon signal transduction: viral VHl phosphatase reverses Stat1 activation. J. Virol. 75: 3185-3196 (2001) https://doi.org/10.1128/JVI.75.7.3185-3196.2001
  12. Denu, J.M. and Dixon, J.E. A catalytic mechanism for the dualspecific phosphatases. Proc. Natl. Acad. Sci. USA 92: 5910-5914 (1995) https://doi.org/10.1073/pnas.92.13.5910
  13. Terrence, R.B. and Zhang, Z.Y. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery. Biopolymers 47: 225-241 (1998) https://doi.org/10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O
  14. Hamaguchi, T, Sudo, T. and Osada, H. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at Gl phase. FEBS betters 372: 54-58 (1995) https://doi.org/10.1016/0014-5793(95)00953-7
  15. Han, D.Y. Modem Pharmacognosy, 8th ed., pp. 446-447. Hakchangsa, Seoul (1994)
  16. Huang, K.C. The pharmacology of Chinese herbs, p. 138, CRC Press, Boca Ranton, USA (1993)
  17. Hunter, T. Oncoprotein networks. Cell 88: 333-346 (1997) https://doi.org/10.1016/S0092-8674(00)81872-3
  18. Ishibashi, T, Bottaro, D.P., Chan, A., Miki, T. and Aaronson, S.T. Expression and cloning of a human dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 89: 12170-12174 (1992)
  19. Tonks, N.K., Diltz, C.D. and Fischer, E.H. Characterization of the major protein tyrosine phosphatases of human placenta. J. Biol. Chem. 263: 6731-6737 (1988)
  20. Zander, N.F., Lorenzen, J.A., Cool, D.E., Tonks, N.K., Daum, G., Krebs, E.G. and Fischer, E.H. Purification and Characterization of a human recombinant T-cell protein tyrosine phosphatase from a baculovirus expression system. Biochemistry 30: 6964-6970 (1991)
  21. Zhang, Z., Bai, G., Deans, Z.S., Browner, M.F. and Lee, E.Y.C. Expression of the catalytic subunit of phosphorylase (protein phosphatase-l) in Escherichia coli. J. Biol. Chem. 267: 1484-1490 (1992)
  22. Monks, A., Scudiero, D., Skchan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J. and Boyd, M. Feasi bility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83: 757-766 (1991) https://doi.org/10.1093/jnci/83.11.757
  23. Lee, B.H., Lee, S.J., Kang, T.H., Kim, D.H., Sohn, D.H., Ko, J.I. and Kim, Y.C. Baicalein: An in vitro antigenotoxic compound from Scutellaria baicalensis. Planta Medica 66: 70-71 (2000)
  24. Gao, Z., Huang, K., Yang, X. and Xu, H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutallaria. baicalensis Georgi. Biochim, Biophys. Acta 1472: 643-650 (1999) https://doi.org/10.1016/S0304-4165(99)00152-X
  25. Nakahata, N., Kyo, R., Kutsuwa, M. and Ohizumi, Y. Inhibition of mitogen-activated protein kinase cascade by baicalein, a flavonoid of natural origin. Nippon Yakungaku Zasshi 114: 215-219 (1999) https://doi.org/10.1254/fpj.114.supplement_215